Core Scientific Inc Stock Price, News & Analysis

Tradr ETFs (Cboe: COZX) launched the Tradr 2X Long CORZ Daily ETF on Nov 5, 2025, seeking 200% daily exposure to Core Scientific (Nasdaq: CORZ). The fund is listed on Cboe and joins Tradr's AI-infrastructure suite.

Tradr reports a lineup of 49 leveraged ETFs representing over $2.2 billion AUM. The product targets sophisticated investors and short-term traders and emphasizes leverage risks, potential divergence from benchmark over periods longer than the reset, and the possibility of total loss if CORZ moves >50% adverse in one day.

Two Seas Capital (NASDAQ:CORZ) commented on the outcome of Core Scientific's special meeting held on October 30, 2025, where shareholders rejected the company's proposed sale to CoreWeave (NASDAQ:CRWV).

Two Seas, identified as one of Core Scientific's largest shareholders, thanked fellow shareholders for rejecting the transaction and reiterated confidence in Core Scientific's management and strategy. The statement urged focus on growing the power pipeline, securing additional contracts, and building next-generation data centers, and said Two Seas will work constructively with the company to pursue long-term value creation.

Core Scientific (Nasdaq: CORZ) will host an investor conference call and live audio webcast today, October 30, 2025, at 11:30 AM Eastern Time. Management participants include Adam Sullivan (CEO), Matt Brown (COO), Jim Nygaard (CFO) and Jon Charbonneau (VP, Investor Relations).

Investors can access the live webcast via the Investors section of Core Scientific’s website at https://investors.corescientific.com. An audio replay will be archived on the same investor relations page after the event.

Core Scientific (NASDAQ: CORZ) announced that a special meeting of stockholders failed to deliver the votes required to approve the previously announced merger agreement with CoreWeave, and, pursuant to the merger agreement, Core Scientific terminated the merger agreement effective October 30, 2025. The company said it will remain a publicly traded issuer and its common stock will continue to trade on Nasdaq under the ticker CORZ.

Core Scientific (Nasdaq: CORZ) announced on October 30, 2025 that at a special meeting of stockholders the company did not receive the requisite votes to approve its previously announced merger agreement with CoreWeave (Nasdaq: CRWV).

The company said the final voting results will be reported in a Form 8-K to be filed with the U.S. Securities and Exchange Commission.

Two Seas Capital (NASDAQ: CORZ) issued a letter on Oct 28, 2025 urging Core Scientific shareholders to vote AGAINST the proposed sale to CoreWeave (announced July 7, 2025). Two Seas says the deal values Core Scientific at $16.40 per share and argues that Core Scientific has materially higher standalone upside—claiming the stock would trade at more than twice the deal value if aligned with AI-infrastructure peers.

The letter highlights Core Scientific's access to low-cost power, operational expertise, and a 700-megawatt pipeline, and warns that approving the transaction would transfer value to CoreWeave. Shareholders face a vote at a special meeting on Oct 30, 2025.

Core Scientific (NASDAQ: CORZ) reported fiscal Q3 2025 results with total revenue $81.1M versus $95.4M a year earlier and gross profit $3.9M vs. a prior-year gross loss. Digital asset self-mining revenue fell to $57.4M, driven by a 55% decline in bitcoin mined despite an 88% higher average bitcoin price. High-density colocation revenue rose to $15.0M from $10.3M. Net loss narrowed to $146.7M from $455.3M, partly due to smaller non-cash fair-value adjustments. Adjusted EBITDA was a $2.4M loss. Q3 capital expenditures totaled $244.5M, of which $196.4M was funded by CoreWeave. Liquidity stood at $694.8M (cash $453.4M; bitcoin $241.4M). CoreWeave proposed an all-stock merger at an exchange ratio of 0.1235, with a stockholder vote scheduled for October 30, 2025.

CoreWeave (NASDAQ: CRWV) commented on proxy-advisor recommendations opposing its proposed all-stock acquisition of Core Scientific (NASDAQ: CORZ), urging CORZ stockholders to vote FOR on the WHITE proxy card on October 30, 2025. CoreWeave says the agreed transaction represents fair value, notes there will be no increase to the offer price, and asserts no other buyer has emerged since its June 2024 approach. Under the definitive agreement signed July 7, 2025, Core Scientific shareholders will receive 0.1235 newly issued CoreWeave Class A shares per CORZ share. The boards of both companies unanimously approved the merger, which is expected to close in Q4 2025, subject to customary closing conditions including regulatory and stockholder approval.

Two Seas Capital urged Core Scientific shareholders (NASDAQ: CORZ) to vote AGAINST the proposed sale to CoreWeave (NASDAQ: CRWV) announced July 7, 2025. Two Seas argues the deal substantially undervalues Core Scientific, citing market moves since the announcement: several peer data-center/HPC stocks have roughly tripled, while CoreWeave's stock has fallen ~15%, leaving the implied deal value near $17.50 per share.

Two Seas highlights Core Scientific trading ~12% above the deal value as of Oct 16, 2025, and that the stock traded above the implied value for 44 straight days, urging shareholders to reject the transaction on the GOLD proxy card.